2-(2-oxo-1H-pyridin-3-yl)-N-(2-pyrrolidin-1-ylpyridin-4-yl)-5,6,7,8-tetrahydroquinoline-8-carboxamide | 1227054-82-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-(2-oxo-1H-pyridin-3-yl)-N-(2-pyrrolidin-1-ylpyridin-4-yl)-5,6,7,8-tetrahydroquinoline-8-carboxamide
• CAS: 1227054-82-1
• 化学式: C₂₄H₂₅N₅O₂
• 分子量: 415.495
• InChiKey: NOYMEMGFDRJLDQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  31
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  87.2
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• [EN] PYRIDINE, BICYCLIC PYRIDINE AND RELATED ANALOGS AS SIRTUIN MODULATORS<br/>[FR] PYRIDINE, PYRIDINE BICYCLIQUE ET ANALOGUES ASSOCIÉS EN TANT QUE MODULATEURS DE SIRTUINE
  申请人：SIRTRIS PHARMACEUTICALS INC

  公开号：WO2010056549A1

  公开（公告）日：2010-05-20

  The present invention provides novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders relating to aging or stress, diabetes, obesity, neurodegenerative disease, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorder that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent. The compounds are of general formula (III) wherein R1, R2, R", X, Y, W, Z1 and Z2 are as defined in the specification.

  本发明提供了新颖的调节sirtuin的化合物以及其使用方法。这些调节sirtuin的化合物可用于延长细胞寿命，并用于治疗和/或预防与衰老或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块障碍、炎症、癌症、潮红以及需要增加线粒体活性的疾病或疾病。还提供了包含sirtuin调节化合物与另一治疗剂组合的组合物。这些化合物的一般化学式为（III），其中R1、R2、R"、X、Y、W、Z1和Z2如规范中定义。
• PYRIDINE, BICYCLIC PYRIDINE AND RELATED ANALOGS AS SIRTUIN MODULATORS
  申请人：Narayan Radha

  公开号：US20110263564A1

  公开（公告）日：2011-10-27

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了一种新型的调节sirtuin的化合物及其使用方法。这些sirtuin调节化合物可用于延长细胞寿命，治疗和/或预防各种疾病和障碍，包括与衰老或压力相关的疾病或障碍、糖尿病、肥胖症、神经退行性疾病、心血管疾病、血液凝块障碍、炎症、癌症和/或潮红，以及需要增加线粒体活性的疾病或障碍。此外，还提供了包含sirtuin调节化合物与另一种治疗剂联合使用的组合物。